HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Doctors, clinical officers, nurses, laboratory technologists, pharmacists, community health workers and staff funded by the US Government have been impacted. Service Disruptions: Some facilities ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

A study presented at CROI 2025 reveals that a single-question self-efficacy measure effectively predicts ART adherence and viral load suppression among pregnant women with HIV in Malawi, offering a ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Kenya requires Sh 5.24 billion for the 2024/2025 fiscal year and Sh 13.5 billion for 2025/2026 to maintain its current HIV response.

Unsurprisingly, obese individuals (BMI 30-34.9 kg/m 2) had the highest prevalence of EVAF (88%) in the study, followed by class II obese PWH (BMI 35-40 kg/m 2; 69%). However, EVAF was still present in ...

Many healthcare and social services depend on international aid. Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and severe ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...